Updated: 2/14/2022

There are many resources available online about all aspects of cancer (fewer specifically devoted to post-transplant risks, but other information would still be applicable for post-transplant issues), MANY (literally 100's) of which are listed here:

TRIO Full-length Cancer-related Videos by our PTC medical faculty:

The TRIO Transplant Presentation Library features many full-length post-transplant cancer presentations by medical staff that are available on YouTube.  Most are either one-on-one interviews or support group presentations, some over an hour in length as transplant recipients in the audience question, and engage in discussion with these noted presenters. Segments from these recordings are found throughout this PTC website in support of appropriate subject pages.  They are listed here for further access convenience, duplicating their listing in that Transplant Presentation Library index which can be found along with over 100+ transplant-related videos that are not cancer-focused, but of patient interest. Note: the indexed/topic-searchable full TRIO Transplant Presentation Library is available at https://www.trioweb.org/resources/transplant-presentation-library-dvd-program.html

• Pgm #137: Cancer as a transplant recipient: Understand Your Risks and What to Do" by Jim Gleason with Dr. David Reich
• Pgm #136: "Successful living in spite of the higher risk for cancer post transplant" by Jim Gleason with Dr. Mark Abdelmalek
• Pgm #75: "Cancer & Transplant - How to maintain your health and well-being" by Dr. David Reich (liver focus)
• Pgm #94: "Beyond Year Two Post-transplant - Looking into the future: by Dr. Lee Goldberg (heart focus)
• PTLD and Blood Cancer Research - an interview with Dr. David Tsai (blood cancer focus)
• Pgm #81: "Post-transplant Malignancies" by Dr. Rhondalyn McLean (cancer focus)
• Pgm #28: "Skin Cancer Post-transplant" by Dr. Chris Miller (transplant Dermatology & Mohs surgery focus)
• Pgm #84a: "Heart Transplant Patients & Cancer" by Dr. Thuzar Shin (cancer in heart patients focus)
• Pgm #97: "Skin Cancer in Transplant Patients" by Kelly MacArthur (dermatology focus)
• Pgm #84a: "Heart Transplant Patients & Cancer" by Dr. Chris Miller (skin cancer focus)
• Pgm #88: "Post-transplant Cancer & Stress" a one-on-one interview with Dr. Peter Swanljung (psychology focus)
• Pgm #79: "When a Patient Becomes Your Surgeon" by Dr. Silke Niederhaus (kidney focus)
• Pgm #105: "Skin Cancer After Transplant - What to know and how to protect yourself" by Leora Aizman & Elizabeth May Hayward (skin cancer focus)
• from BAAKP, "Skin Cancer Risks after Kidney Transplant" by Sarah Aaron, MD, PhD

TRIO Post-transplant Cancer workshop slide set:
Slides used at 2016 TGA (Transplant Games of America) PTC workshop

The AJT (American Journal of Transplantation) ran a 12‐month series of articles about cancer, a major complication of solid organ transplantation and gave TRIO public access so they could be offered here:

• "Behind the Scenes of a Radical New Cancer Cure" 11/10/2019
• Cancer in Solid Organ Transplant Recipients: There Is Still Much to Learn and Do
• Chemotherapy and Transplantation: The Role of Immunosuppression in Malignancy and a Review of Antineoplastic Agents in Solid Organ Transplant Recipients
• Breast Cancer and Transplantation
• Skin Cancers in Organ Transplant Recipients
• Comprehensive Review on Colorectal Cancer and Transplant
• Palliative and end of life care in solid organ transplantation
• Urologic malignancies in kidney transplantation
• Comprehensive review of post–organ transplant hematologic cancers
• Gynecologic cancers and solid organ transplantation

 NCI Dictionary of Cancer Terms
The NCI Dictionary of Cancer Terms features 8,545 terms related to cancer and medicine.

Directory of clinical trials:
> NIH: ClinicalTrials.gov
> National Cancer Institute clinical trials search tool
> PTLD Clinical Trials fact sheet

Cancer Support Groups:
> AICR contact listing of support groups by cancer type
> Lung Cancer Center

Cancer general resources:

• Spectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US Mar 14. 2022
• Cancer rates high among long-term kidney transplant recipients (Renal & Urology News) Feb 2022
• Risks of Multiple Skin Cancers in Organ Transplant Recipients (A Cohort Study) Oct 20, 2021
• Life-years lost due to cancer among solid organ transplant recipients in the United States, 1987 to 2014 Sep 20, 2021
• Cancer-attributable mortality among solid organ transplant recipients in the United States: 1987 through 2014 Apr 29, 2019
• Survival after a cancer diagnosis among solid organ transplant recipients in the United States Jan 9, 2019
• Improving cancer-specific outcomes in solid organ transplant recipients: Where to begin? Jan 9, 2019
• Does Medicare Cover Cancer Treatment? (Healthline article)
• Cancer Associated with Overweight and Obesity
• How Mindfulness Meditation Can Help Cancer Survivors Cope with Stress
• 20 Common Cancer Symptoms to Catch Early 3/11/2020
• "After Cancer Took His Mother, James Allison Taught Our Immune Systems How to Fight It" 2/6/2020
• "The Decade of Immunotherapy: Highlights from the 2010s" 12/31/2019:
  As of 2019, immunotherapy has permanently changed the cancer treatment landscape,
  resulting in FDA approvals for more than a dozen types of cancers,
  thousands of lives saved, and even a Nobel Prize.
  When it comes to cancer, it’s hard to deny that this was the decade of immunotherapy.
• Staying on Guard Against Skin Cancer NY Times 10 14 2019
• "Cancer-Attributable Mortality Among Solid Organ Transplant
  Recipients in the United States: 1987 Through 2014" 9/1/2019
• Cancer Immunotherapy and you (a patient education webinar series playlist on youtube by CRI) 8/30/2019
• Incidence and Risk Factors of Keratinocyte Carcinoma After First Solid Organ Transplant in Ontario, Canada 5/22/2019
• Cancer Immunotherapy and You (video) 8/14/2019
• Scientists develop novel nano-vaccine for melanoma 8/6/2019
• Cancer Immunotherapy and You Webinar Series playlist on YouTube 7/24/2019
• Stem Cell Therapy explained 5/8/2019
• 30 Cancer Symptoms You Should Never Ignore 2/20/2019
• Australia melanoma research: Queensland researchers to trial 'cancer-stopping' stem cell drug 1/9/2019
• Risk High, Prognosis Poor for Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients 1/3/2019
• Blood Test to Detect Early-stage Melanoma Developed 1/1/2019
• Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients 12/31/2018
• 51 Things Dermatologists Need You to Know About Skin Cancer 12/30/2018
• A medical search tool: Notify Library
• Chasing Cancer: A Washington Post panel event (discussion videos) 12/3/2018
• Medical condition resource search tool: P2L: Prescription to Learn 8/22/2018
• Cancer education resource: CANCER101 Empower Organize Inform
• National Cancer Institute
• Cancer Research Institute: Immunotherapy
• Cancer Research Institute
• American Cancer Society
• Medscape
• WebMD
• Clinical Trials
• Cancer Treatment Centers of America
• Cancer in America (PublicHealth.org) also: http://www.publichealth.org/public-awareness/cancer/additional-resources/
• Cancer journals, Courseware, Research organizations, Professional organizations and Public Awareness organizations (PublicHealth.org)
• Israel Penn International Transplant Tumor Registry (and here's a link to their publications)
• American Institute for Cancer Research: Tools You Can Use
• AICR: Cancer Infographics & Multimedia (an educational resource)
• AICR: Cancer Prevention 30 day planner PDF
• US Government booklet for Cancer Survivors PDF download
• Click to download UCSF informational pamphlet: "Skin Cancer: An Introduction for Organ Transplant Recipients" 
• Sign up for Transplant Skin Cancer Network Survey <-- click here for invitation)
• Cancer Screening Guidelines by Age
• What to Expect During Your Prostate Exam
• Skin Cancer Screening: What to Expect
• What to Expect During, Before, and After Radiation Treatment
• Cancer Causing Agents - Carcinogens
• Coping with Cancer: 10 Steps Towards Emotional Well-Being
• What are the Short and Long Term Side Effects of Chemotherapy?
• Skin cancer common after organ transplant (1/11/2017 article)
• FREE Cancer Resource: Living with Cancer 10/20/2017
• Health GPS: General Cancer (medical search tool) (11/15/2018)

Cancer articles & videos of interest:

• "What's the sunscreen situation?" 8/30/2019
• Cut unhealthy behaviors to reduce cancer mortality by one third 8/13/2019
• Pro and anti-cancer effects of immunosuppressive agents used in organ transplant 6/27/2004
• Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients 11/2/2011 
• Cancer Immunotherapy and You Webinar Series playlist on YouTube 7/24/2019
• Survival after a cancer diagnosis among solid organ transplant recipients in the United States 1/9/2019
• How the Microbiome Could Be the Key to New Cancer Treatments 3/7/2019
• 4 Important Steps to Take After a Cancer Diagnosis 2/13/2019
• Scientists may have found a way to treat cancer without chemotherapy by replicating our body's own self-destruct system 1/15/2019
• Australian researchers develop 10-minute cancer test 12/5/2018
•  How Scientists Are Treating Breast Cancer Using the Immune System 10/4/2018
• Study results: Up to Date Screenings Cut CRC Deaths 10/2/2018
•  Immunotherapy Drugs Slow Skin Cancer That Has Spread to the Brain 8/22/2018
• Sirolimus for secondary prevention of skin cancer in kidney transplant recipients: 5-year results 7/25/2018
• Organ transplant patients have increased skin cancer risk 84/2018
• 14 Cancer Warning Signs Your Doctor Should Never Ignore (a Reader's Digest article) - 8/1/2018
• Breaking the rules of science to treat cancer - 7/17/2018
• Ten Ways to Lower Your Cancer Risk - 6/7/2018
• MORE HOPE IN THE NEWS: Grail’s cancer blood test shows ‘proof of principle,’ but challenges remain 6/4/2018
• Doctors hail world first as woman’s advanced breast cancer is eradicated 6/4/2018
• Research rundown: using nanorobots to seek and destroy cancer 5/15/2018
• Sleep and Cancer 4/11/2018
• First aid for People with Cancer 4/5/2018
• FREE PDF download by CRI: Cancer and the Immune System: The Vital Connection 12/1/2017
• FDA approves a game-changing treatment for blood cancer 10/19/2017
• 15 Cancer Symptoms Women Are Likely to Ignore 10/18/2017
• PTSD and Life After Cancer 10/11/2017
• 7 Side Effects of Cancer Treatment and How to Cope With Them 10/17/2017
• Eating Well During and After Your Cancer Treatment 10/11/2017
• Living with Cancer: Eight Things You Need to Know 10/11/2017
• Sleep and cancer (TUCK web article with related resource links)
• Cancer's Invasion Equation (by the same author of the fascinating book, The Emperor of All Maladies, A Biography of Cancer) 9/5/2017
• There's a New Way to Treat Cancer! 9/1/2017
• Cancer's Newest Miracle Cure
• Melanoma Risk Higher in Kidney Transplant Recipients
• 6 Findings on Exercise and Cancer Risk
• Surprising Facts About Melanoma
• Study finds low rate of cancer screening among transplant patients
• Skin Cancer in Heart Transplant Recipients: Risk Factor Analysis and Relevance of Immunosuppressive Therapy (study from 2000)
• Transplant Patients Have More Infections After Mohs Surgery
• Scientists usher in new era of cancer research
• Study: African-American Organ Transplant Recipients at Risk for Skin Cancer
• Inconsistent guidelines for screening transplant recipients at higher cancer risk: Canadian study
• Immunosuppressed Melanoma Patients Have More Aggressive Disease
• Animated Introduction to Cancer Biology (video)
• 4 Rays of Hope for 'Precision' Cancer Therapies
• Most Cancer Is Beyond Your Control, Breakthrough Study Finds
• More Evidence of Exercise for Cancer Prevention
• The Nutrition Label, "Healthy' and Cancer Prevention
• 3 Steps for Cancer Survivors to Live Healthier
• Harvesting the Immune System to Fight Cancer
• What is Immunotherapy? The Basics on These Cancer Treatments

Immunosuppressant drugs:

• Calcineurin inhibitors:
  Gengraf, Neoral,  Sandimmune (generic name: cyclosporine)
  Hecoria, Prograf, Astagraf XL (generic name: tacrolimus)

• mTOR inhibitors:
  Afinitor, Afinitor Disperz, Zortress (generic name: everolimus)
  Torisel (generic name: temsirolimus)
  Rapamune (generic Name: sirolimus)

Cancer in Transplant Recipients:

• Cancer in the Transplant Recipient - Jeremy R. Chapman, Angela C. Webster and Germaine Wong
• RNA sequencing characterized high-risk squamous cell carcinomas 
• National Cancer Institute: Transplant Cancer Match Study

Skin cancer resources:

• ITNS Skin Cancer booklet (PDF download)
• American Academy of Dermatology
• International Transplant Skin Cancer Collaborative (. . . and click here for a link to their publications)
• Mollie's Fund (Melanoma/tanning)

Kidney cancer resources:

• Renal Cell Carcinoma (42 slides)

Financing for Fighting Cancer:

• Newspaper article on Crowdfunding: http://www.nbcnews.com/nightly-news/how-crowdfunding-helps-patients-deal-high-cost-cancer-care-n370176

Blood cancer resources:

• The Leukemia & Lymphoma Society - for help or to learn more about specific blood cancers: www.lls.org/diseaseinformation/

Immunosuppression/Immunodeficiency and Cancer:

• Proceedings from 2012 ITSCC conference: 
  http://www.itscc.org/UserFiles/file/Cummins%2520ITSCC%2520Presentation.pdf
• Int J Cancer. 2013 Mar 15;132(6):1429-38. doi: 10.1002/ijc.27765. Epub 2012 Aug 28: Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study.
• Am J Transplant. 2013 Jan;13(1):174-83. doi: 10.1111/j.1600-6143.2012.04302.x. Epub 2012 Oct 24. Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients.
• Harris JP, Penn I: Immunosuppression and development of malignancies of the upper airway. Laryngoscope 91:520–528, 1981.
• Immunosuppression and Merkel cell cancer. Transplant Proc 2002 Aug;34(5):1780–1
• Penn I, Brunson ME: Cancers following cyclosporine therapy. Transplant Proc 20 (Suppl 3):885–892, 1988.
• Penn I, First MR: Development and incidence of cancer following cyclosporine therapy. Transplant Proc 18:210–213, 1986.
• Penn I, Starzl TE: Immunosuppression and cancer. Transplant Proc 5:943–947, 1973.
• Penn I, Starzl TE: Immunosuppression and neoplasia. ALG Therapy and Standardization Workshop. Behring Institute Research Communications No. 51, Behring-Werke, Marburg, West Germany. (ed Seiler FR and Schwick HG) pp. 204–208, 1972.
• Penn I, Starzl TE: The effect of immunosuppression on cancer. In Seventh National Cancer Conference Proceedings. Philadelphia, J.B. Lippincott Co., pp. 425–436, 1973.
• Penn I: Cancer associated with immunosuppression. Chapter in CRC Handbook Series in Clinical Laboratory Science. Section F: Immunology Vol. 1, Part 2 (eds Baumgarten A and Richards FF) Cleveland, Ohio CRC Press Inc., pp. 365–375, 1979.
• Penn I: Cancer following cyclosporine therapy. Transplant Proc 19:2211–2213, 1987.
• Penn I: Cancer in immunosuppressed patients. In Symposia Medica Hoechst 21 The Nature, Cellular and Biochemical Basis and Management of Immunodeficiencies. (eds Good RA and Lindenlaub E). F.K. Shattauer Verlag, Stuttgart, pp. 271–288, 1987.
• Penn I: Cancer in immunosuppressed patients. Transplant Proc 16:492–494, 1984.
• Penn I: Cancer in immunosuppressed patients. Transplant Proc 7 (Suppl. 1) 553–555, 1975.
• Penn I: Cancer in the immunosuppressed organ recipient. Transplant Proc 23:1771–1772, 1991.
• Penn I: Cancer is a long-term hazard of immunosuppressive therapy. In Immunointervention in Autoimmune Diseases (ed Bach JF). London Academic Press, pp. 49–62, 1989.
• Penn I: Cancer is a long-term hazard of immunosuppressive therapy. J Autoimmunity 1:545–558, 1988.
• Penn I: Cancers after cyclosporine therapy. Transplant Proc 20(Suppl):276–279, 1988.
• Penn I: Cancers following cyclosporine therapy. Transplantation 43:32–34, 1987.
• Penn I: Chemical immunosuppression and human cancer. Cancer 34:1474–1480, 1974.
• Penn I: Cyclosporine and oncogenesis. Mount Sinai J Med 54:460–464, 1987.
• Penn I: Depressed immunity and the development of cancer: A review. Clin Exp Immunol 46:459–474, 1981.
• Penn I: Immunosuppression and cancer: Importance in head and neck surgery. Arch Otolaryngol 101:667–670, 1975.
• Penn I: Immunosuppression and malignant disease. Chapter in Comprehensive Immunology — 4 — The Immunopathology of Lymphoreticular Neoplasms (eds Twomey JJ and Good RA) Plenum Medical Book Company, New York, pp. 223–237, 1978.
• Penn I: Immunosuppression and opportunistic tumors: Do viruses play a role? In Advances in tumor immunology and allergic disorders, Immuno Incontri (ed F. Dammacco). Milan, Edi. Ermes, pp. 139–162, 1992
• Penn I: Immunosuppressive agents, immunodeficiency states and malignancy. In Lieberman R and Mukherjee A (Eds), Principles of Drug Development in Transplantation and Autoimmunity, Austin, Texas, RG Landes, New York, Chapman and Hall, pp. 93–102, 1996.
• Penn I: Malignancies associated with immune deficiencies. In Comprehensive Textbook of Oncology, (eds Moossa AR, Schimpf SC and Robson MC), Second Edition Baltimore, Williams and Wilkins Co., pp. 115–119, 1991.
• Penn I: Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery 83:492–502, 1978.
• Penn I: Malignancies following the use of Cyclosporin A in man. Cancer Surveys 1(4):621–624, 1983.
• Penn I: Malignant disease in immunodeficient states in man. In Recent Results in Cancer Research (eds Grundmann E and Gross R) Vol. 52:96–106, 1975.
• Penn I: Malignant neoplasia in the immunocompromised patient. In The Transplantation and Replacement of Thoracic Organs. The present status of biological and mechanical replacement of the heart and lungs. (eds Cooper DKC and Novitzky D) Dordrecht Kluwer Academic Publishers, pp. 183–190, 1990.
• Penn I: Mechanisms of therapy induced malignancies — editorial review. Cancer Surveys 1(4):763–782, 1983.
• Penn I: Neoplastic consequences of immunosuppression. In Immunotoxicology and Immunopharmacology. (eds Dean JH, Luster MI, Munson AE, Amos H) New York, Raven Press, pp. 79–89, 1985.
• Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl. 1998:147–58.
• Penn I: Occurrence of cancers in immunosuppressed organ transplant recipients. In Clinical Transplants 1994, Terasaki PI and Cecka JM (Eds). UCLA Tissue Typing Laboratory, pp. 99–109, 1995.
• Penn I: Occurrence of malignancies in immunosuppressed organ transplant recipients. In Organ Transplantation 1990 (eds Abouna GM, Kumar MSA, White AG). Dordrecht, Kluwer Academic Publishers, pp. 475–483, 1991.
• Penn I. Post-transplant malignancy: the role of immunosuppression. Drug Saf. 2000 Aug;23(2):101–13.
• Penn I: Second malignant neoplasms associated with immunosuppressive medications. Cancer 37:1024–1032, 1976.
• Penn I: The neoplastic consequences of immunodepression. In Immunotoxicology. (eds Berlin A, Deal J, Draper MH, Smith EMB, Spreafico F). Dordrecht, Martinus Nijhoff Publishers, pp. 69–82, 1987.
• Penn I: The occurrence of cancer in immune deficiencies. Current Problems in Cancer 6(10) 1–64, April 1982.
• Penn I: The occurrence of malignant tumors in immunosuppressed states. In Acquired Immunodeficiency Syndrome (ed Klein E) Basel, Karger. (Progress in Allergy Series) Vol. 37, pp. 259–300, 1986.`
• Penn I: Why do immunosuppressed patients develop cancer? In CRC Critical Reviews in Oncogenesis (ed Pimentel E). Boca Raton, Florida CRC Press Inc., Vol. 1, pp. 27–52, 1989.
• Porreco R, Penn I, Droegemueller W, Greer B, Makowski E: Gynecologic malignancies in immunosuppressed organ homograft recipients. Obstet Gynec 45:359–364, 1975.
• Schwartz RS, Penn I: Immunosuppression and neoplasia. Transplant Proc 7 (Suppl. 1) 899–900, 1975.
• Starzl TE, Penn I, Halgrimson CG: Immunosuppression and malignant neoplasms. (letter to the editor) New Eng J Med 283:934, 1970.
• The role of immunosuppression in lymphomas. Recent Results Cancer Res 2002;159:55–66. Review.
• Yakupoglu YK, Buell JF, Woodle S, Kahan BD. Individualization of immunosuppressive therapy. III. Sirolimus associated with a reduced incidence of malignancy. Transplant Proc. 2006;38(2):358–61.

 Publications from the Transplant Cancer Match Study:

(click on the title above to learn more about this collaborative study that produced the papers listed below)

1. Morton LM, Gibson TM, Clarke CA, Lynch CF, Anderson LA, Pfeiffer R, Landgren O, Weisenburger DD, Engels EA. Risk of myeloid neoplasms after solid organ transplantation. Leukemia. 2014 Dec;28(12):2317-23.
2. Wetmore JB, Calvet JP, Yu AS, Lynch CF, Wang CJ, Kasiske BL, Engels EA. Polycystic kidney disease and cancer after renal transplantation. J Am Soc Nephrol. 2014 Oct;25(10):2335-41.
3. Koshiol J, Pawlish K, Goodman MT, McGlynn KA, Engels EA. Risk of hepatobiliary cancer after solid organ transplant in the United States. Clin Gastroenterol Hepatol. 2014 Sep;12(9):1541-9.
4. Gibson TM, Engels EA, Clarke CA, Lynch CF, Weisenburger DD, Morton LM. Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States. Am J Hematol. 2014 Jul;89(7):714-20.
5. Engels EA, Castenson D, Pfeiffer RM, Kahn A, Pawlish K, Goodman MT, Nalesnik MA, Israni AK, Snyder J, Kasiske B. Cancers among US organ donors: a comparison of transplant and cancer registry diagnoses. Am J Transplant. 2014 Jun;14(6):1376-82.
6. Morton LM, Gibson TM, Clarke CA, Lynch CF, Weisenburger DD, Engels EA. Hepatitis B or C virus infection and risk of non-Hodgkin lymphoma among solid organ transplant recipients. Haematologica. 2014 May;99(5):70-3.
7. Madeleine MM, Finch JL, Lynch CF, Goodman MT, Engels EA. HPV-related cancers after solid organ transplantation in the United States. Am J Transplant. 2013 Dec;13(12):3202-9.
8. Hall EC, Engels EA, Montgomery RA, Segev DL. Cancer risk after ABO-incompatible living-donor kidney transplantation. Transplantation. 2013 Sep 15;96(5):476-9.
9. Clarke CA, Morton LM, Lynch C, Pfeiffer RM, Hall EC, Gibson TM, Weisenburger DD, Martínez-Maza O, Hussain SK, Yang J, Chang ET, Engels EA. Risk of lymphoma subtypes after solid organ transplantation in the United States. Br J Cancer. 2013 Jul 9;109(1):280-8.
10. Engels EA, Clarke CA, Pfeiffer RM, Lynch CF, Weisenburger DD, Gibson TM, Landgren O, Morton LM. Plasma cell neoplasms in US solid organ transplant recipients. Am J Transplant. 2013 Jun;13(6):1523-32.
11. Hall EC, Pfeiffer RM, Segev DL, Engels EA. Cumulative incidence of cancer after solid organ transplantation. Cancer. 2013 Jun 15;119(12):2300-8.
12. Mbulaiteye SM, Clarke CA, Morton LM, Gibson TM, Pawlish K, Weisenburger DD, Lynch CF, Goodman MT, Engels EA. Burkitt lymphoma risk in U.S. solid organ transplant recipients. Am J Hematol. 2013 Apr;88(4):245-50.
13. Hall EC, Segev DL, Engels EA. Racial/ethnic differences in cancer risk after kidney transplantation. Am J Transplant. 2013 Mar;13(3):714-20.
14. Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL, Fleissner ML, Goodman MT, Kahn A, Koch L, Lynch CF, Madeleine MM, Pawlish K, Rao C, Williams MA, Castenson D, Curry M, Parsons R, Fant G, Lin M. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011 Nov 2;306(17):1891-901.

Post-transplant Cancer References
(from an article at https://jamanetwork.com/journals/jama/fullarticle/1104578 )

1. US Department of Health and Human Services.  Organ Procurement and Transplantation Network. http://optn.transplant.hrsa.gov/. Accessed May 5, 2011
2. Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation.  Int J Cancer. 2009;125(8):1747-175419444916PubMedGoogle ScholarCrossref
3. Birkeland SA, Storm HH, Lamm LU,  et al.  Cancer risk after renal transplantation in the Nordic countries, 1964-1986.  Int J Cancer. 1995;60(2):183-1897829213PubMedGoogle ScholarCrossref
4. Collett D, Mumford L, Banner NR,  et al.  Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit.  Am J Transplant. 2010;10(8):1889-189620659094PubMedGoogle ScholarCrossref
5. Villeneuve PJ, Schaubel DE, Fenton SS,  et al.  Cancer incidence among Canadian kidney transplant recipients.  Am J Transplant. 2007;7(4):941-94817331115PubMedGoogle ScholarCrossref
6. Vajdic CM, McDonald SP, McCredie MR,  et al.  Cancer incidence before and after kidney transplantation.  JAMA. 2006;296(23):2823-283117179459
ArticlePubMedGoogle ScholarCrossref

7.

Adami J, Gäbel H, Lindelöf B,  et al.  Cancer risk following organ transplantation: a nationwide cohort study in Sweden.  Br J Cancer. 2003;89(7):1221-122714520450PubMedGoogle ScholarCrossref

8.

Kyllönen L, Salmela K, Pukkala E. Cancer incidence in a kidney-transplanted population.  Transpl Int. 2000;13:(suppl 1)  S394-S39811112040PubMedGoogle ScholarCrossref

9.

Serraino D, Piselli P, Angeletti C,  et al.  Risk of Kaposi's sarcoma and of other cancers in Italian renal transplant patients.  Br J Cancer. 2005;92(3):572-57515668710PubMedGoogle Scholar

10.

Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States.  Am J Transplant. 2004;4(6):905-91315147424PubMedGoogle ScholarCrossref

11.

Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.  Lancet. 2007;370(9581):59-6717617273PubMedGoogle ScholarCrossref

12.

Bouvard V, Baan R, Straif K,  et al; WHO International Agency for Research on Cancer Monograph Working Group.  A review of human carcinogens—part B: biological agents.  Lancet Oncol. 2009;10(4):321-32219350698PubMedGoogle ScholarCrossref

13.

Chaturvedi AK, Mbulaiteye SM, Engels EA. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.  Ann Epidemiol. 2008;18(3):230-23418083545PubMedGoogle ScholarCrossref

14.

Breslow NE, Day NE. The Design and Analysis of Cohort Studies. Vol II. Lyon, France: International Agency for Research on Cancer; 1987

15.

Surveillance, Epidemiology and End Results Program.  SEER*Stat Database: Incidence - SEER 17 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases. http://seer.cancer.gov/data/metadata.html. Accessed May 5, 2011

16.

Kasiske BL, Vazquez MA, Harmon WE,  et al; American Society of Transplantation.  Recommendations for the outpatient surveillance of renal transplant recipients.  J Am Soc Nephrol. 2000;11:(suppl 15)  S1-S8611044969PubMedGoogle Scholar

17.

Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma.  Cancer Epidemiol Biomarkers Prev. 2006;15(10):1765-177717035381PubMedGoogle ScholarCrossref

18.

Swindle P, Falk M, Rigby R,  et al.  Transitional cell carcinoma in renal transplant recipients: the influence of compound analgesics.  Br J Urol. 1998;81(2):229-2339488064PubMedGoogle ScholarCrossref

19.

Layman AB, Engels EA. Kidney and bladder cancers among people with AIDS in the United States.  J Acquir Immune Defic Syndr. 2008;48(3):365-36718580342PubMedGoogle ScholarCrossref

20.

Harris NL, Swerdlow SH, Frizzera G, Knowles DM. Post-transplant lymphoproliferative disorders. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:264-269

21.

van Leeuwen MT, Grulich AE, Webster AC,  et al.  Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation.  Blood. 2009;114(3):630-63719443660PubMedGoogle ScholarCrossref

22.

Faull RJ, Hollett P, McDonald SP. Lymphoproliferative disease after renal transplantation in Australia and New Zealand.  Transplantation. 2005;80(2):193-19716041263PubMedGoogle ScholarCrossref

23.

Quinlan SC, Pfeiffer RM, Morton LM, Engels EA. Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States.  Am J Hematol. 2011;86(2):206-20921264909PubMedGoogle ScholarCrossref

24.

Cockfield SM. Identifying the patient at risk for post-transplant lymphoproliferative disorder.  Transpl Infect Dis. 2001;3(2):70-7811395972PubMedGoogle ScholarCrossref

25.

Andreone P, Gramenzi A, Lorenzini S,  et al.  Posttransplantation lymphoproliferative disorders.  Arch Intern Med. 2003;163(17):1997-200414504111
ArticlePubMedGoogle ScholarCrossref

26.

Opelz G, Döhler B. Lymphomas after solid organ transplantation: a collaborative transplant study report.  Am J Transplant. 2004;4(2):222-23014974943PubMedGoogle ScholarCrossref

27.

Minai OA, Shah S, Mazzone P,  et al.  Bronchogenic carcinoma after lung transplantation: characteristics and outcomes.  J Thorac Oncol. 2008;3(12):1404-140919057264PubMedGoogle ScholarCrossref

28.

Dickson RP, Davis RD, Rea JB, Palmer SM. High frequency of bronchogenic carcinoma after single-lung transplantation.  J Heart Lung Transplant. 2006;25(11):1297-130117097492PubMedGoogle ScholarCrossref

29.

Ritchie AJ, Mussa S, Sivasothy P, Stewart S. Single-lung transplant complicated by unexpected explant carcinoma: a management dilemma.  J Heart Lung Transplant. 2007;26(11):1206-120818022089PubMedGoogle ScholarCrossref

30.

Abrahams NA, Meziane M, Ramalingam P,  et al.  Incidence of primary neoplasms in explanted lungs.  Transplant Proc. 2004;36(9):2808-281115621155PubMedGoogle ScholarCrossref

31.

Engels EA. Inflammation in the development of lung cancer: epidemiological evidence.  Expert Rev Anticancer Ther. 2008;8(4):605-61518402527PubMedGoogle ScholarCrossref

32.

Thuluvath PJ, Guidinger MK, Fung JJ,  et al.  Liver transplantation in the United States, 1999-2008.  Am J Transplant. 2010;10(4 pt 2):1003-101920420649PubMedGoogle ScholarCrossref

33.

Mazzaferro V, Regalia E, Doci R,  et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.  N Engl J Med. 1996;334(11):693-6998594428PubMedGoogle ScholarCrossref

34.

Hoffmann CJ, Subramanian AK, Cameron AM, Engels EA. Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation.  Transplantation. 2008;86(6):784-79018813102PubMedGoogle ScholarCrossref

35.

Goh A, Vathsala A. Native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients.  Am J Transplant. 2011;11(1):86-9220973916PubMedGoogle ScholarCrossref

36.

Heinz-Peer G, Schoder M, Rand T,  et al.  Prevalence of acquired cystic kidney disease and tumors in native kidneys of renal transplant recipients: a prospective US study.  Radiology. 1995;195(3):667-6717753991PubMedGoogle Scholar

37.

de Mattos AM, Olyaei AJ, Bennett WM. Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future.  Am J Kidney Dis. 2000;35(2):333-34610676738PubMedGoogle ScholarCrossref

38.

Guba M, Graeb C, Jauch KW, Geissler EK. Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation.  Transplantation. 2004;77(12):1777-178215223891PubMedGoogle ScholarCrossref

39.

Welch HG, Black WC. Overdiagnosis in cancer.  J Natl Cancer Inst. 2010;102(9):605-61320413742PubMedGoogle ScholarCrossref